enVVeno Medical Shares Positive Interim Results from VenoValve Pivotal Study enVVeno Medical Corporation (NVNO), a medical device company focused on treating deep venous disease, reported encouraging two-year interim data from its pivota

#NVNO has announced positive interim results from its pivotal VenoValve® study, showcasing significant improvements for patients with chronic venous insufficiency. A promising step forward in vascular health innovation.
#enVVenoMedical
prismmarketview.com/envveno-medi...